GlassScriptPhysician profile
Angela Mirzadeh
NPI 1619537966
$4,915.44
in general payments reported to CMS, 2019-2025
9 companies · $3,029 in 2025
The $3,029 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2023: $201 · 2024: $1,567 · 2025: $3,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $796.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $4,000.00 | 2024-2025 | Bovine Collagen |
| Biogen, INC. | $383.48 | 2024-2025 | Zurzuvae, Vumerity |
| Hologic Sales and Service, LLC | $263.59 | 2019-2023 | Acessa Provu System |
| Organon LLC | $71.05 | 2024-2025 | Nexplanon |
| Abbvie INC. | $64.69 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $47.32 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $42.71 | 2025 | |
| Shield Therapeutics INC | $23.38 | 2023 | Accrufer |
| Astellas Pharma US INC | $19.22 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mirzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.